The nociceptin/orphanin FQ/NOP receptor system as a target for treatment of alcohol abuse: A review of recent work in alcohol-preferring rats

Physiology and Behavior

Volumn 79, Issue 1, 2003, Pages 121-128

  Ciccocioppo, Roberto ^a   Economidou, Daina ^a   Fedeli, Amalia ^a   Massi, Maurizio ^a  

^a UNIVERSITY OF CAMERINO   (Italy)

Author keywords

Alcohol intake; Alcohol seeking behavior; Nociceptin orphanin FQ; NOP receptor; Relapse; Reward

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; 8 (2,3,3A,4,5,6 HEXAHYDRO 1H PHENALEN 1 YL) 1 PHENYL 1,3,8 TRIAZASPIRO[4.5]DECAN 4 ONE; AMINO ACID; BICUCULLINE; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR BLOCKING AGENT; HETEROCYCLIC COMPOUND; LIGAND; MORPHINE; NALOXONE; NALTREXONE; NOCICEPTIN; NOCICEPTIN DERIVATIVE; NOCICEPTIN RECEPTOR; NOCICEPTIN[1-12]AMIDE; NOCICEPTIN[1-13]AMIDE; NOCICEPTIN[1-13][1 N PHENYLALANINE]AMIDE; NOCICEPTIN[1-17]AMIDE; UNCLASSIFIED DRUG;

ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ALCOHOLISM; AMINO ACID SEQUENCE; ANOREXIA; CARBOXY TERMINAL SEQUENCE; CONFERENCE PAPER; DISEASE MODEL; DOPAMINERGIC SYSTEM; DRINKING BEHAVIOR; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; DRUG SELECTIVITY; DRUG TARGETING; ELECTRIC SHOCK; EXPERIMENTAL RAT; GENETIC SELECTION; HUMAN; NEUROMODULATION; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; RAT STRAIN; REWARD; STRESS;

EID: 0038614844     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-9384(03)00112-4     Document Type: Conference Paper

References (92)

1. Anton B., Fein J., To T., Li X., Silberstein L., Evans C.J. Immunohistochemical localization of ORL-1 in the central nervous system of the rat. J. Comp. Neurol. 368:1996;229-251.
2. Benjamin D., Grant E.R., Pohorecky L.A. Naltrexone reverses the ethanol-induced dopamine release in the nucleus accumbens in awake, freely moving rats. Brain Res. 621:1993;137-140.
3. Bontempi B., Sharp F.R. Systemic morphine-induced Fos protein in the rat striatum and nucleus accumbens is regulated by mu opioid receptors in the substantia nigra and ventral tegmental area. J. Neurosci. 17:1997;8596-8612.
4. Brown S.A., Vik P.W., Patterson T.L., Grant I., Schuckit M.A. Stress, vulnerability and adult alcohol relapse. J. Stud. Alcohol. 56:1995;538-545.
5. Calo' G., Guerrini R., Rizzi A., Salvadori S., Regoli D. Pharmacology of nociceptin and its receptor: a novel therapeutic target. Br. J. Pharmacol. 129:2000;1261-1283.
6. 2, a new selective nociceptin receptor antagonist. Br. J. Pharmacol. 129:2000;1183-1193.
7. Calo' G., Rizzi A., Bigoni R., Guerrini R., Salvadori S., Regoli D. Pharmacological profile of nociceptin/orphanin FQ receptors. Clin. Exp. Pharmacol. Physiol. 29:2002;223-228.
8. Ciccocioppo R., Angeletti S., Panocka I., Massi M. Nociceptin/orphanin FQ and drugs of abuse. Peptides. 21:2000;1071-1080.
9. Ciccocioppo R., Angeletti S., Sanna P.P., Weiss F., Massi M. Effect of nociceptin/orphanin FQ on the rewarding properties of morphine. Eur. J. Pharmacol. 404:2000;153-159.
10. Ciccocioppo R., Biondini M., Antonelli L., Wichmann J., Jenck F., Massi M. Reversal of stress- and CRF-induced anorexia in rats by the synthetic nociceptin/orphanin FQ receptor agonist, Ro 64-6198. Psychopharmacology. 161:2002;113-119.
11. Ciccocioppo R., Fedeli A., Economidou D., Massi M. Nociceptin/orphanin FQ and its receptor as a target for treatment of alcohol abuse. 2002 Scientific Meeting of the RSA and 11th Congress of the ISBRA, San Francisco, CA, June 28-July 3, 2002. Alcohol. Clin. Exp. Res. 26:2002;104A.
12. Ciccocioppo R., Martin-Fardon R., Weiss F. Effect of selective blockade of mu(1) or delta opioid receptors on reinstatement of alcohol-seeking behavior by drug-associated stimuli in rats. Neuropsychopharmacology. 27:2002;391-399.
13. Ciccocioppo R., Martin-Fardon R., Weiss F., Massi M. Nociceptin/orphanin FQ inhibits stress- and CRF-induced anorexia in rats. NeuroReport. 12:2001;1145-1149.
14. Ciccocioppo R., Panocka I., Froldi R., Quitadamo E., Massi M. Ethanol induces conditioned place preference in genetically selected alcohol-preferring rats. Psychopharmacology. 141:1999;235-241.
15. Ciccocioppo R., Panocka I., Polidori C., Regoli D., Massi M. Effect of nociceptin on alcohol intake in alcohol-preferring rats. Psychopharmacology. 141:1999;220-224.
16. Ciccocioppo R., Polidori C., Antonelli L., Salvadori S., Guerrini R., Massi M. Pharmacological characterization of the nociceptin receptor which mediates reduction of alcohol drinking in rats. Peptides. 23:2002;117-125.
17. Cooney N.L., Gillespie R.A., Baker L.H., Kaplan R.F. Cognitive changes after alcohol cue exposure. J. Consult. Clin. Psychol. 55:1987;150-155.
18. Cooney N.L., Litt M.D., Morse P.A., Bauer L.O., Grupp L. Alcohol cue reactivity, negative-mood reactivity, and relapse in treated alcoholic men. J. Abnorm. Psychol. 106:1997;243-250.
19. Cox B.M., Chavkin C., Christie M.J., Civelli O., Evans C., Hamon M.D.et al. Opioid receptors. Girdlstone D. The IUPHAR Compendium of receptor characterization and classification. 2000;321-333 IUPHAR Media, London.
20. Darland T., Heinricher M.M., Grandy D.K. Orphanin FQ/nociceptin: a role in pain and analgesia, but so much more. Trends Neurosci. 21:1998;215-221.
21. Devine D.P., Reinscheid R.K., Monsma F.J. Jr., Civelli O., Akil H. The novel neuropeptide orphanin FQ fails to produce conditioned place preference or aversion. Brain Res. 727:1996;225-229.
22. Devine D.P., Leone P., Carlezon W.A. Jr., Wise R.A. Ventral mesencephalic delta opioid receptors are involved in modulation of basal mesolimbic dopamine neurotransmission: an anatomical localization study. Brain Res. 622:1993;348-352.
23. Devine D.P., Leone P., Wise R.A. Mesolimbic dopamine neurotransmission is increased by administration of mu-opioid receptor antagonists. Eur. J. Pharmacol. 243:1993;55-64.
24. Di Chiara G., North R.A. Neurobiology of opiate abuse. Trends Pharmacol. Sci. 13:1992;185-193.
25. Di Chiara G. The role of dopamine in drug abuse viewed from the perspective of its role in motivation. Drug Alcohol Depend. 38:1995;95-137.
26. Di Giannuario A., Pieretti S., Catalani A., Loizzo A. Orphanin FQ reduces morphine-induced dopamine release in the nucleus accumbens: a microdialysis in rats. Neurosci. Lett. 272:1999;183-186.
27. Eriksen L., Gotestam K.G. Conditioned abstinence in alcoholics: a controlled experiment. Int. J. Addict. 19:1984;287-294.
28. 3H]nociceptin binding sites from telencephalic to mesencephalic regions of the mouse brain. Neurosci. Lett. 230:1997;33-36.
29. Gessa G.L., Colombo G., Fadda F. Rat lines genetically selected for difference in voluntary ethanol consumption. Meltzer H.Y., Nerozzi D. Current practices and future developments in the pharmacotherapy of mental disorders. 1991;193-200 Excerpta Medica, Amsterdam.
30. Gessa G.L., Muntoni F., Collu M., Vargiu L., Mereu G.P. Low doses of ethanol activate dopaminergic neurons in the ventral tegmental area. Brain Res. 348:1985;201-203.
31. Grahame N.J., Mosemiller A.K., Low M.J., Froehlich J.C. Naltrexone and alcohol drinking in mice lacking beta-endorphin by site-directed mutagenesis. Pharmacol. Biochem. Behav. 67:2000;759-766.
32. Gonzales R.A., Weiss F. Suppression of ethanol-reinforced behavior by naltrexone is associated with attenuation of the ethanol-induced increase in dialysate dopamine levels in the nucleus accumbens. J. Neurosci. 18:1998;10663-10671.
33. Hawes B.E., Graziano M.P., Lambert D.G. Cellular actions of nociceptin: transduction mechanisms. Peptides. 21:2000;961-967.
34. Henderson G., McKnight A.T. The orphan opioid receptor and its endogenous ligand nociceptin/orphanin FQ. Trends Pharmacol. Sci. 18:1997;293-300.
35. Herz A. Endogenous opioid systems and alcohol addiction. Psychopharmacology. 129:1997;99-111.
36. Ikeda K., Watanabe M., Ichikawa T., Kobayashi T., Yano R., Kumanishi T. Distribution of pre-pro-nociceptin/orphanin FQ mRNA and its receptor mRNA in developing and adult mouse central nervous systems. J. Comp. Neurol. 399:1998;139-151.
37. Imperato A., Di Chiara G. Preferential stimulation of dopamine release in the nucleus accumbens of freely moving rats by ethanol. J. Pharmacol. Exp. Ther. 239:1986;219-228.
38. Jenck F., Moreau J.L., Martin J.R., Kilpatrick G.J., Reinscheid R.K., Monsma F.J. Jr.et al. Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress. Proc. Natl. Acad. Sci. 94:1999;14854-14858.
39. Jenck F., Wichmann J., Dautzenberg F.M., Moreau J.L., Ouagazzal A.M., Martin J.R.et al. A synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: anxiolytic profile in the rat. Proc. Natl. Acad. Sci. USA. 97:2000;4938-4943.
40. Johnson S.W., North R.A. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J. Neurosci. 12:1992;483-488.
41. Kaplan R.F., Cooney N.L., Baker L.H., Gillespie R.A., Meyer R.E., Pomerleau O.F. Reactivity to alcohol-related cues: physiological and subjective responses in alcoholics and nonproblem drinkers. J. Stud. Alcohol. 46:1985;267-272.
42. Katner S.N., Magalong J.G., Weiss F. Reinstatement of alcohol-seeking behavior by drug-associated discriminative stimuli after prolonged extinction in the rat. Neuropsychopharmacology. 20:1999;471-479.
43. Kotlinska J., Wichmann J., Legowska A., Rolka K., Silberring J. Orphanin FQ/nociceptin but not Ro 65-6570 inhibits the expression of cocaine-induced conditioned place preference. Behav. Pharmacol. 13:2002;229-235.
44. Koster A., Montkowski A., Schulz S., Stube E.M., Knaudt K., Jenck F.et al. Targeted disruption of the orphanin FQ/nociceptin gene increases stress susceptibility and impairs stress adaptation in mice. Proc. Natl. Acad. Sci. USA. 96:1999;10444-10449.
45. Kuzmin A., Sandin J., Terenius L., Ogren S.O. Acquisition, expression, and reinstatement of ethanol-induced conditioned place preference in mice: effects of opioid receptor-like 1 receptor agonists and naloxone. J. Pharmacol. Exp. Ther. 304:2003;310-318.
46. Laberg J.C. Alcohol and expectancy: subjective, psychophysiological and behavioral responses to alcohol stimuli in severely, moderately and non-dependent drinkers. Br. J. Addict. 81:1986;797-808.
47. Le A.D., Harding S., Juzytsch W., Fletcher P.J., Shaham Y. The role of corticotropin-releasing factor in the median raphe nucleus in relapse to alcohol. J. Neurosci. 22:2002;7844-7849.
48. Le A.D., Harding S., Juzytsch W., Watchus J., Shalev U., Shaham Y. The role of corticotrophin-releasing factor in stress-induced relapse to alcohol-seeking behavior in rats. Psychopharmacology. 150:2000;317-324.
49. Le A.D., Poulos C.X., Harding S., Watchus J., Juzytsch W., Shaham Y. Effects of naltrexone and fluoxetine on alcohol self-administration and reinstatement of alcohol seeking induced by priming injections of alcohol and exposure to stress. Neuropsychopharmacology. 21:1999;435-444.
50. Le A.D., Quan B., Juzytch W., Fletcher P.J., Joharchi N., Shaham Y. Reinstatement of alcohol-seeking by priming injections of alcohol and exposure to stress in rats. Psychopharmacology. 135:1998;169-174.
51. Leventhal L., Mathis J.P., Rossi G.C., Pasternak G.W., Bodnar R.J. Orphan opioid receptor antisense probes block orphanin FQ-induced hyperphagia. Eur. J. Pharmacol. 349:1998;R1-R3.
52. Leventhal L., Stevens L.B., Rossi G.C., Pasternak G.W., Bodnar R.J. Antisense mapping of the MOR-1 opioid receptor clone: modulation of hyperphagia induced by DAMGO. J. Pharmacol. Exp. Ther. 282:1997;1402-1407.
53. Lindholm S., Ploj K., Franck J., Nylander I. Nociceptin/orphanin FQ tissue concentration in the rat brain. Effects of repeated ethanol administration at various post-treatment intervals. Prog. Neuropsychopharmacol. Biol. Psychiatry. 26:2002;303-306.
54. Liu X., Weiss F. Additive effect of stress and drug cues on reinstatement of ethanol seeking: exacerbation by history of dependence and role of concurrent activation of corticotropin-releasing factor and opioid mechanisms. J. Neurosci. 22:2002;7856-7861.
55. Liu X., Weiss F. Reversal of ethanol-seeking behavior by D1 and D2 antagonists in an animal model of relapse: differences in antagonist potency in previously ethanol-dependent versus nondependent rats. J. Pharmacol. Exp. Ther. 300:2002;882-889.
56. Maidment N.T., Chen Y., Tan A.M., Murphy N.P., Leslie F.M. Rat ventral midbrain dopamine neurons express the orphanin FQ/nociceptin receptor ORL-1. NeuroReport. 13:2002;1137-1140.
57. Martin-Fardon R., Ciccocioppo R., Massi M., Weiss F. Nociceptin prevents stress-induced ethanol- but not cocaine-seeking behavior in rats. NeuroReport. 11:2001;1939-1943.
58. Meunier J.C., Mollereau C., Toll L., Suaudeau C., Moisand C., Alvinerie P.et al. Isolation and structure of the endogenous agonist of opioid receptor- like ORL1 receptor. Nature. 377:1995;532-535.
59. Meunier J.C. Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor. Eur. J. Pharmacol. 340:1997;1-15.
60. Mogil J.S., Grisel J.E., Reinscheid R.K., Civelli O., Belknap J.K., Grandy D.K. Orphanin FQ is a functional anti-opioid peptide. Neuroscience. 75:1996;333-337.
61. Mogil J.S., Grisel J.E., Zhangs G., Belknap J.K., Grandy D.K. Functional antagonism of mu-, delta- and kappa-opioid antinociception by orphanin FQ. Neurosci. Lett. 214:1996;131-134.
62. Mogil J.S., Pasternak G.W. The molecular and behavioral pharmacology of the orphanin FQ/nociceptin peptide and receptor family. Pharmacol. Rev. 53:2001;381-415.
63. Monti P.M., Binkoff J.A., Abrams D.B., Zwick W.R., Nirenberg T.D., Liepman M.R. Reactivity of alcoholics and nonalcoholics to drinking cues. J. Abnorm. Psychol. 96:1987;122-126.
64. Monti P.M., Rohsenow D.J., Rubonis A.V., Niaura R.S., Sirota A.D., Colby S.M.et al. Alcohol cue reactivity: effects of detoxification and extended exposure. J. Stud. Alcohol. 54:1993;235-245.
65. Monti P.M., Rohsenow D.J., Hutchison K.E., Swift R.M., Mueller T.I., Colby S.M.et al. Naltrexone's effect on cue-elicited craving among alcoholics in treatment. Alcohol. Clin. Exp. Res. 23:1999;1386-1394.
66. Murphy N.P., Lee Y., Maidment N.T. Orphanin FQ/nociceptin blocks acquisition of morphine place preference. Brain Res. 832:1999;168-170.
67. Murphy N.P., Ly H.T., Maidment N.T. Intracerebroventricular orphanin FQ/nociceptin suppresses dopamine release in the nucleus accumbens of anaesthetized rats. Neuroscience. 75:1996;1-4.
68. Murphy N.P., Maidment N.T. Orphanin FQ/nociceptin modulation of mesolimbic dopamine transmission determined by microdialysis. J. Neurochem. 73:1999;179-186.
69. Neal C.R. Jr., Mansour A., Reinscheid R., Nothacker H.P., Civelli O., Watson S.J. Jr. Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat. J. Comp. Neurol. 406:1999;503-547.
70. Norton C.S., Neal C.R., Kumar S., Akil H., Watson S.J. Nociceptin/orphanin FQ and opioid receptor-like receptor mRNA expression in dopamine systems. J. Comp. Neurol. 444:2002;358-368.
71. Nothacker H.P., Reinscheid R.K., Mansour A., Henningsen R.A., Ardati A., Monsma F.J. Jr.et al. Primary structure and tissue distribution of the orphanin FQ precursor. Proc. Natl. Acad. Sci. USA. 93:1996;8677-8682.
72. O'Brien C., Childress A.R., Ehrman R., Robbins S., McLellan A.T. Conditioning mechanisms in drug dependence. Clin. Neuropharmacol. 15(Suppl 1 Pt. A):1992;66A-67A.
73. O'Brien C.P., Childress A.R., Ehrman R., Robbins S.J. Conditioning factors in drug abuse: can they explain compulsion? J. Psychopharmacol. 12:1998;15-22.
74. Panocka I., Ciccocioppo R., Mosca M., Polidori C., Massi M. Effects of the dopamine D1 receptor antagonist SCH 39166 on the ingestive behaviour of alcohol-preferring rats. Psychopharmacology. 120:1995;227-235.
75. Ploj K., Roman E., Gustavsson L., Nylander I. Basal levels and alcohol-induced changes in nociceptin/orphanin FQ, dynorphin, and enkephalin levels in the C57BL/6J mice. Brain Res. Bull. 53:2000;219-226.
76. Polidori C., Calo' G., Ciccocioppo R., Guerrini R., Regoli D., Massi M. Pharmacological characterization of the nociceptin receptor mediating hyperphagia: identification of a selective antagonist. Psychopharmacology. 148:2000;430-437.
77. Polidori C., de Caro G., Massi M. The hyperphagic effect of nociceptin/orphanin FQ in rats. Peptides. 21:2000;1051-1062.
78. Pomonis J.D., Billington C.J., Levine A.S. Orphanin FQ agonist of orphan opioid receptor ORL1, stimulates feeding in rats. NeuroReport. 8:1996;369-371.
79. Reinscheid R.K., Ardati A., Monsma F.J. Jr., Civelli O. Structure-activity relationship studies on the novel neuropeptide orphanin FQ. J. Biol. Chem. 271:1996;14163-14168.
80. Reinscheid R.K., Higelin J., Henningsen R.A., Monsma F.J. Jr., Civelli O. Structures that delineate orphanin FQ and dynorphin A pharmacological selectivities. J. Biol. Chem. 273:1998;1490-1495.
81. Reinscheid R.K., Nothacker H.P., Bourson A., Ardati A., Henningsen R.A., Bunzow J.R.et al. Orphanin FQ: a neuropeptide that activates an opioid-like G protein-coupled receptor. Science. 270:1995;792-794.
82. Rohsenow D.J., Monti P.M., Hutchison K.E., Swift R.M., Colby S.M., Kaplan G.B. Naltrexone's effects on reactivity to alcohol cues among alcoholic men. J. Abnorm. Psychol. 109:2000;738-742.
83. Shaham Y., Erb S., Stewart J. Stress-induced relapse to heroin and cocaine seeking in rats: a review. Brain Res. Rev. 33:2000;13-33.
84. Sim L.J., Childers S.R. Anatomical distribution of mu, delta, and kappa opioid- and nociceptin/orphanin FQ-stimulated [35S]guanylyl-5′-O-(gamma-thio)-triphosphate binding in guinea pig brain. J. Comp. Neurol. 386:1997;562-572.
85. Schlicker E., Morari M. Nociceptin/orphanin FQ and neurotransmitter release in the central nervous system. Peptides. 21:2000;1023-1029.
86. Stratford T.R., Holahan M.R., Kelley A.E. Injections of nociceptin into nucleus accumbens shell or ventromedial hypothalamic nucleus increase food intake. NeuroReport. 8:1997;423-426.
87. Swerdlow N.R., Gilbert D., Koob G.F. Conditioned drug effects on spatial preference. Boulton A.A., Baker G.B., Greenshaw A.J. Neuromethods in psychopharmacology. vol. 13:1989;399-446 Humana Press, Clifton (NJ).
88. Volpicelli J.R., Alterman A.I., Hayashida M., O'Brien C.P. Naltrexone in the treatment of alcohol dependence. Arch. Gen. Psychiatry. 49:1992;876-880.
89. + conductance. Neuroendocrinology. 67:1998;73-82.
90. Weiss F., Maldonado-Vlaar C.S., Parsons L.H., Kerr T.M., Smith D.L., Ben-Shahar O. Control of cocaine-seeking behavior by drug-associated stimuli in rats: effects on recovery of extinguished operant-responding and extracellular dopamine levels in amygdala and nucleus accumbens. Proc. Natl. Acad. Sci. USA. 97:2000;4321-4326.
91. Weiss F., Ciccocioppo R., Parsons L.H., Katner S., Liu X., Zorrilla E.P.et al. Compulsive drug-seeking behavior and relapse. Neuroadaptation, stress, and conditioning factors. Ann. N.Y. Acad. Sci. 937:2001;1-26.
92. Weiss F., Lorang M.T., Bloom F.E., Koob G.F. Oral alcohol self-administration stimulates dopamine release in the rat nucleus accumbens: genetic and motivational determinants. J. Pharmacol. Exp. Ther. 267:1993;250-258.